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JVP. rales. edema. SJ. creat~nmc. cardlolhoraclc raho, and the use of drgoxm. 
ACE mhlbllan. dnnettcs and patasslum suppfemonts. Amang tho Valtdallon 
Set. the prodlcled EF was wilhm 0.05 PI a patroni’s measured numanc value 
In only 44% of cases. Howover, a prodtcled EF cut pomt was found, below 
whrch 97 1% of patlenls had a measured EF 0 45 (spoc~f~c~ty = 89%. sea 
lablo). 
Conc/us~onsr 1) Ctmlcal featureri dtsllnguIsh a subsat of paltanfs whose 
EF IS almost always . 0.45. rind. 2) the other subsat, a larger group, WIII 
requtra acfunf measummcnt of EF II II 1s to bF, known. 
I’Q”“-391 Brain Natrlumtlc PeptIde Is a CCN+QffQQth’Q 
Dlagnoatlc Nlarker of VenIricular Dysfunction 
K. M?nn?cta. J.C. Sumctl. Jr. E.A. Rannuder. M.M. Hcdlteld MI)TJ Ch-vc, 
Rochester. MN. USA 
There IS growtng rnteresl In tha use of natnurr?ttc popfldes as serum markers 
of LV dysfuncfwn. To cfetemvne II this approach is cost-effecl~ve. we anafyred 
Srain nalnuretic peptlde (RNP) and eteclron fraction (EF) m 466 conseculfive 
out.pallenls (pls) referred for echo spectf~catfy to check EF because ot symp- 
tome of or nsk taclors for LV dysfuncfion. The prevalence of scgnlhcanl L\r 
dysluncllon (EF .35’%) was 4.7% An abnormal BNP was deftned as .37 
pglmt which IS ,2 SD abOve the mean value in normals. The senstMty and 
specthaly af an abnormal BNP for lhe daleclion of EF -i 351 were 9Q% and 
61%. The probabkly of an EF -- 35% wivith an abnormal BNP was 10.2%. The 
pmbabllily of an EF . 35% with a nomraf BNP was 0.6%. Of the 466 pts. 189 
had an abnormal BNP. Ustng these data and charges for 2-D echo ($463.00) 
and EINP (S50.00); a sample cosl ana@ls was perlomwd. In a hypolhetlcal 
population of loo0 out-p& at risk for LV dysfunction wth a moderate (4.7%) 
prevalence of LV dysfunclion. using BNP lo screen for LV dysfunclron and 
reservmg echo lor those with an abnormal value for BNP would result m 
a 51% cost savings (appmximately S225.OQO m IWO pts) as compared to 
pedormtng echo on all pts. The nsk of LV dysfunchon m a patlent wtth a 
normal BNP value would be quite low (. l?O) m a population v&h tfvs preva- 
lence Mea$unng serum levels 01 BNP represents a cost effectwe means of 
effectwely screemrg pts for LV systolic dysfunction. 
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The most common etrology of congestwe heart fatlure (CHF) rn the United 
States is coronary artery disease. However. the mle at dtagnoslrc coronary 
arieriography (CATf-f) for the pnmary mdicdlion 01 heart failure and no pren- 
ous history 01 myocardiaf infarction (MI) or known previous comnary disease 
(PCAD) is uncerlam. Tfvs IS important as heart failure secondary lo com- 
nary disease may be reversible with revasculanzatron. Thus in 392 patlenls 
with no MI or PCAD who underwent CATH. 251 (64”.) had no CAD 8 141 
(36%) had CAD. Multivariate correlales of CAD were age (odds ratio 1.68 per 
decade). male (odds ratio 2.29) and diabetes (odds rat10 4.74) (see table). 
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Chest pam was not predictive of coronary drsease in this population. For 
a 40 Year old woman wvllhout diabetes the probabtllty 01 CAD was 7 38’0 
while for a 60 Year old man with diabetes the probablllly of CAD was 70 9’. 
These data suggest that patients with heart failure may be StratIfled. Slmlfar 
IO patients with chest pain, with low nsk paltents needing no further testing. 
intermediate risk patients requiring non-invasive evaluation 10 modify the 
probability of CAD prior to the decision on periorming or not perfO~ing 
CATH and high risk patients often requiring CATH for anatomic definition and 
possible revascularization. 
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BaCk$routi: Swchronous p~ctng 01 Ihe nght and leff atna has bean shown lo 
Prevent paroxysmal alnal fibnltation (AF) In pilflenls with prolonged rnlra_afnaf 
condudlon. We dtwmd a prospective mndomrsed fnaf BI a pdot SW* IO 
dslWmlno Ihe leasablkfy of usmg sYnchmrvsed bt.atnal pnccng (SAP) via 
cPfCardlaf wires to provont AF after cardiopulmonary bypass 
&@fhods: 76 Pelloi~tO undergomg I~r$t~ltrne CABG. m sinus mylhm pm. 
oporatlvety wifh no pnor hlstoty of AF, were mndomtsed lo poa-operatwe 
BAP (AAT mode) or contmf Pairs of epIcardIaI wlrea were placed on each 
atnum (RA. LA). Pacing was commenced wdhin 4 hours of surgery and con- 
llnued for 96 hours. Pacing parameters were measured dally Episodes of 
AF 30 mans or r~qumng frealmenl were noled. 
R@Su!fS- No differences In age. ofher baselme demographIcs or cllmcal 
vanabtes were detecled between the groups. Atnal electrograms (AE) and 
dtaslotrc thresholds (DT) m the SAP group were as toflows (mean f SEM). 
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Synchmmsed BAP was successfully malntamed m all cases IO 96 hours 
wdh no complications. The mcrdenca of AF was 18.2% wlh SAP vs 26.7% 
an conlmls (p = 0.13). wllh a srgnificant reducl~on in the median duration ot 
breakthrough episodas of AF (10 hrs vs 48 hrs, p = 0.035) 
Concrusron. EAP m lhe posl-operatlve penod ~!i techntcally leasable. eaaly 
marntained and produced favourable trends m the inadence and duration of 
AF. A larger randomlsed tnal IS being conducted lo clanfy the ckmcal UIIIIIY of 
ttvs lechmque. 
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Background: Previous sludres have shown that AAI pactng f& to suppress 
atnal ftbnllatton (AF) after cornnary artery bypass surgery (CASG). 
Obpctwes: To determme it alnal pncrng (AP) usmg a pacemaker with 
enhanced atnal sensmg. automatic mojc-switching (AMS) and consfsfent 
afrial overdrive pacing capabilities woulo prevent pastopemllve AF. 
Methods: 86 patients (~1s) were randomized lo AP (Paced) ~5. no AP 
(Control), All pts were ccw~necte(l wa temporary eplcardlal wlreS lo a dual 
chamber rate-responswe pocumnk% (hledtromc Thera DR MN 4940) with 
AMS capabiklies enabled and event counters. Paced pls were programmed 
lo AP at a tower rate of 60 ppm and an upper rate km11 of I30 PPm wllh the 
use of a conslslent AP algorithm that matnlatned AP al 50 ms above Ihe 
natwrl atnaf rate. The pnmary endpofnt was development 01 AF of dumllon 
.lQ mlnules requmng pharrnacologlcal or electrical inlewentlon. 
&s&r- AF OCWWJ m ilm3 (34%4 Paced and Ill43 (3496) Controt pls. 
p = 1 .O Pts wtth AF were slgnlhcanfly older (68 : 7.7 vs. 62 f 6.7 YE. P = 
0.007) AF occurred In 9r22 (41”.) Paced and 8120 (40’0) Control Pts .65 
Yrs old (p = 0.9) and 2/21 (lo”.) Paced and 3/23 (13”0) Controf Pl 55 YE 
otd (p = I .Q). The use of posl-operallve /i-blockers was not assoclaled mlh 
decreased post-operattve AF: 15159 (25%) pts wtth and 7127 (26%) wilhout 
posl-operatwe pblockers had AF. p = 0.96. Pre-operallve Ir-bfocker use or 
p-blocker withdrawal did not affect the mndence of AF. 
Conclus,ons: Atrial overdrive pacing does not prevent AF aner CA9G and 
1~3s should not be routinely advocated for suppresslon 01 posloPemtrve AF 
